Suxia X. Luo
127 Dongming Road
Zhengzhou, 450000, China
Zhengzhou, 450000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 140 publications
Interim analysis of a prospective, multicenter, clinical trial of oxycodone naloxone prolonged-release tablets for severe cancer pain complicated with opioid-induced constipation
Journal: Zhonghua yi xue za zhi
Published: July 21, 2026
Trastuzumab Rezetecan in Human Epidermal Growth Factor Receptor 2-Expressing Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma and Colorectal Cancer: A Multicenter, Open-Label, Phase I Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 04, 2026
Safety, efficacy, and pharmacokinetics of eratrectinib (VC004) in solid tumors with NTRK fusions: phase 1 results from a phase 1/2 study.
Journal: Experimental hematology & oncology
Published: December 23, 2025
A Multinational, Retrospective, Real-World Study: Treatment Patterns in Patients With HER2-Positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Beyond First-line in East Asia (HER2+ GASTA Study).
Journal: Cancer research and treatment
Published: December 05, 2025
Decoding clone evolution in HER2 amplified breast cancer through single-cell and spatial transcriptomics analysis of copy number variations.
Journal: Scientific reports
Published: August 04, 2025
Sacituzumab govitecan in Chinese patients with recurrent/metastatic cervical cancer: Results from the phase 2 EVER-132-003 basket study (NCT05119907).
Journal: Gynecologic oncology
Published: June 02, 2025
Does the posterior-only approach provide adequate treatment for cervical spine metastases with severe vertebral body compromise?
Journal: European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society
Published: April 05, 2025
Glecirasib with or without cetuximab in previously treated locally advanced or metastatic colorectal cancer with KRASG12C mutation (JAB-21822-1002 and JAB-21822-1007): two open-label, non-randomised phase 1/2 trials.
Journal: The lancet. Gastroenterology & hepatology
Published: April 03, 2025
Predicting survival outcomes in renal cell carcinoma spinal metastases: a multicenter evaluation of existing prognostic systems.
Journal: The spine journal : official journal of the North American Spine Society
Published: March 03, 2025
Neoadjuvant camrelizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastroesophageal junction adenocarcinoma: a single-arm, phase 2 trial.
Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Published: January 17, 2025
Impact of restrictive versus liberal transfusion strategy on outcomes in patients undergoing surgery for spinal metastasis: a propensity score-matched analysis.
Journal: Neurosurgical review
Published: January 13, 2025
Intratumoral oncolytic virus OH2 injection in patients with locally advanced or metastatic sarcoma: a phase 1/2 trial.
Journal: Journal for immunotherapy of cancer
Published: December 30, 2024
Last Updated: 09/26/2026